This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations by Stephan Klutz in Virus Inactivation
Introduction
Stephan Klutz is an accomplished inventor based in Leverkusen, Germany. He has made significant contributions to the field of virus inactivation technology. His innovative approach has led to the development of a unique apparatus and method that enhances the safety and efficacy of product streams.
Latest Patents
Stephan Klutz holds 1 patent for his invention titled "Device and method for continuous virus inactivation." This invention provides an apparatus and a process for continuous virus inactivation. The apparatus comprises a tube or hose with an inlet and an outlet connected to a product flow line for conveying the product stream. The design includes a curved and/or helically coiled tube with multiple windings, which alters the direction of action of the centrifugal force, ensuring effective virus inactivation.
Career Highlights
Stephan Klutz is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on innovative solutions that address critical health challenges. His dedication to research and development has positioned him as a key player in his field.
Collaborations
Stephan has collaborated with notable colleagues, including Safa Kutup Kurt and Martin Lobedann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Stephan Klutz's contributions to virus inactivation technology exemplify the impact of innovation in enhancing public health safety. His work continues to inspire advancements in the field, demonstrating the importance of research and collaboration in driving progress.